Brazilian Court Rules on a Decision Allowing Hemp Cultivation

In recent months, we saw a Brazilian court rule on a decision allowing hemp cultivation, a first in the nation’s history. This, coupled with ANVISA’s recent policy announcements concerning its recognition of medicinal cannabis, represents a substantial and swift policy change in Latin America. I have previously written about the significance of the ANVISA announcement,

By |2020-01-24T15:24:08-07:00January 24th, 2020|Global Law|

GUEST POST: Hemp In Guatemala

By Mario Andres Arroyo Unda President of Cañamo Industrial Guatemala Association –CAÑIG- One of cannabis’s subspecies, globally known as hemp, is arising as a commodity and a new industry around the world. Many countries have modified their legislation in order to be part of the supply chain of this new market, and others that have

By |2019-12-18T13:06:02-07:00October 24th, 2019|Global Law|

Mexico Cannabis Update #9

Preview of Medical Cannabis Rules by COFEPRIS Dr. Jose A. Novelo, director of the Federal Commission for the Protection against Sanitary Risks (COFEPRIS) appeared before the Mexican Senate’s Health Committee to discuss the current government’s public health agenda. Not surprisingly, one of the main subjects discussed was the status of the long-awaited regulations for medical

By |2019-12-19T15:31:26-07:00October 17th, 2019|Global Law|

Schoenmaker Humako Sues The Government To Plant Cannabis In Brazil

HLG Global team helps build legal strategy for a lawsuit against the State and the National Health Surveillance Agency (Anvisa) A major flower and potato producer now wants to plant hemp to produce fiber, food, and especially medicines. The company Schoenmaker Humako, which is part of the Terra Viva Group, has filed a lawsuit against

By |2019-12-18T13:14:49-07:00October 17th, 2019|Global Law|

Mexico Cannabis Update #8

New Cannabis Bills Introduced to Senate In the past months, additional bills have been introduced in the Mexican Senate with the intention of regulating cannabis and hemp. As of today, a total of 13 initiatives o proposals to amend existing or enact new laws have been filed in the Senate in addition to another number

By |2019-12-18T12:12:23-07:00October 16th, 2019|Global Law|

GUEST POST: Cannabis, Communities, and Crime: Recent Statistics for Lingering Fears

This article is authored by Tony Gallo, Managing Partner for Sapphire Risk Advisory Group, LLC. Sapphire Risk Advisory Group is a Partner of Hoban Law Group.  Almost every state has legalized cannabis to some extent, whether that be for medical marijuana, broad recreational use, or CBD.  Dispensaries are becoming a common sight in busy cities

By |2019-12-18T12:14:06-07:00October 11th, 2019|Global Law|


The world's leading firm in consultancy for the promotion of hemp-related businesses announces that Ecuador is about to enter the global investment map in this sector. Hemp has great potential to develop the Ecuadorian textile, biofuels, paper, cellulose, bioplastics, lubricants, cosmetics and medicine industries, among others. HLG estimates that as soon as reforms to the

By |2019-12-18T12:26:18-07:00September 25th, 2019|Global Law|

Week In Review – September 20-26, 2019

Cannabis Regulation In Australia Could Be About To Become Way Less Complex Cannabis regulation in Australia has taken a step forward. Last Thursday, a report into the Narcotic Drugs Act (ND Act) was tabled in Parliament, which recommended a major overhaul of the licensing regime for the drug and might see more Australian businesses able to

By |2019-12-18T13:59:24-07:00September 25th, 2019|Global Law, Government and Policy|

Bob Hoban’s CannaTech Panama 2019 Presentation On Global Hemp

Watch HLG President & Founder, Bob Hoban's presentation on Global Hemp at Cannatech Panama 2019.

By |2019-12-18T12:26:57-07:00September 24th, 2019|Global Law|

Mexico Cannabis Update

Resolution of the Supreme Court on the medicinal use of cannabis The Mexican Supreme Court of Justice (SCJN) unanimously approved Justice Eduardo Medina Mora’s proposed draft of a ruling that orders the Health Secretariat and COFEPRIS to issue the necessary regulations for the medicinal use of cannabis and its derivatives within a 180 business days

By |2019-12-18T12:30:02-07:00September 18th, 2019|Global Law|